Conventional wisdom suggests that antipsychotics need similar doses for mania and schizophrenia. This analysis clarifies the exceptions.

You want to protect your manic child or teen patient from metabolic problems associated with most antipsychotics, so you think about using ziprasidone. How likely is it to work? Is it truly well tolerated? We give you our best take on it despite the problems inherent in industry-funded research. 

We struggle to manage the metabolic impact of antipsychotic medications on the children and teens we treat. Could topiramate be a viable option for our armamentarium of strategies? Read our research update to find out. 

Antipsychotics offer remarkable, even lifesaving treatment for children and adolescents, however, their side effects include metabolic and neurologic problems, including neurotoxicity. This clinical update guides you through a rational process for employing these powerful medications when necessary but also reducing and discontinuing them when possible.

This anticonvulsant makes its randomized-controlled debut in bipolar mania.

Clonidine was a promising therapy for mania in the 1980s, but the ball got dropped. This study picks that up with a modern-day randomized-controlled design.